Castellum, Inc. (CTM) - Q2 2024 10-Q Summary
Business Context and Reporting Period
Company: Castellum, Inc.
Reporting Period: Quarter and six months ended June 30, 2024
Business Overview: Castellum provides cybersecurity, IT, electronic warfare, and information operations services primarily to U.S. government agencies, as well as financial services and healthcare sectors. The company operates as a single reporting segment.
Capital Structure: Common stock (56.1M shares outstanding as of Aug 8, 2024), Series A and Series C Preferred stock, and significant warrant/option overhang.
Key Financial Metrics (Six Months Ended June 30, 2024)
| Metric | 2024 (6 Months) | 2023 (6 Months) |
|---|---|---|
| Revenue | $22,857,441 | $22,412,815 |
| Gross Profit | $9,188,629 | $9,249,600 |
| Gross Margin | 40.2% | 41.3% |
| Operating Loss | $(4,241,427) | $(6,563,200) |
| Net Loss | $(5,958,456) | $(6,421,834) |
| Net Loss to Common Shareholders | $(6,018,095) | $(6,481,973) |
| Diluted EPS | $(0.11) | $(0.14) |
| Cash from Operations | $772,346 | $(1,865,051) |
| Cash and Equivalents (End of Period) | $2,411,825 | $2,989,677 |
| Total Debt (Current + Non-Current) | ~$11.8M | ~$11.3M |
Note: Total Debt includes Revolving Credit Facility ($1.53M), Notes Payable ($8.65M), and Related Party Notes ($0.4M). Derivative liabilities of $55,000 are also present.
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 2% year-over-year (YoY) to $22.9M, driven primarily by organic contributions from the GTMR acquisition completed in March 2023.
- Operating Efficiency: Operating expenses decreased 15% YoY to $13.4M. This reduction was largely due to a significant decrease in non-cash stock-based compensation compared to the prior year.
- Profitability: Net loss improved by 7% YoY to $6.0M. The operating loss narrowed by 35% to $4.2M.
- Cash Flow: Operating cash flow turned positive, providing $772k compared to a $1.9M outflow in the prior year. This was driven by lower stock-based compensation and improved collections of accounts receivable.
- Debt Restructuring: In February 2024, the company restructured significant debt obligations, including extinguishing prior notes and entering into a new $4.0M revolving credit facility with Live Oak Bank and a new $6.0M term note.
Guidance, Outlook, and Risks
Management Commentary & Outlook:
- Backlog: Total scheduled backlog stands at $86.4M (Funded: $13.8M, Unfunded: $19.9M, Priced Options: $52.6M). Including unscheduled options, the grand total backlog is $132.8M. Management expects to recognize ~45% of remaining performance obligations in the next 12 months.
- Liquidity: As of June 30, 2024, the company held $2.4M in cash with $2.5M of unused borrowing capacity on its new revolver. Proceeds from a January 2024 registered direct offering (~$2.7M gross) were used to fund operations and debt repayments.
- Executive Changes: Effective July 1, 2024, Glen R. Ives assumed the role of President and CEO, replacing Mark Fuller.
- Government Funding: Revenue is heavily dependent on U.S. government spending. Risks include budget deficits, sequestration, and delays in the FY2025 budget process.
- Customer Concentration: Three customers represented 55% of revenue for the six months ended June 30, 2024.
- Self-Insurance: The company began self-insuring employee health benefits in June 2024. While a stop-loss policy exists, unexpected claims could materially impact financial results.
- Debt Obligations: Significant debt maturities are scheduled for 2024 and 2025. The company relies on refinancing or equity raises to service these obligations.
Investor Verification Checklist
- Debt Maturity Wall: Verify the company's ability to service the $6.0M Eisiminger Note (maturing Aug 2026) and the $2.4M Buckhout Note (monthly payments starting Sept 2024) given current cash flow.
- Backlog Conversion: Assess the risk of the $19.9M unfunded backlog not being appropriated by Congress, which could impact future revenue recognition.
- Stock-Based Compensation: Monitor future quarters for a potential rebound in stock-based compensation expenses, which were significantly lower in 2024 due to timing of grants in 2023.
- Self-Insurance Reserves: Review future filings for adequacy of the $66,620 self-insurance reserve against actual claims experience.
- Equity Dilution: Note the significant number of warrants (18.9M) and options (8.2M) outstanding, which could lead to substantial dilution upon exercise.